Pacific Edge cuts losses by $4.7m on US growth

Pacific Edge cuts losses by $4.7m on US growth
Total lab throughput for tests dipped 6% compared to the prior year.
Brent Melville
Cancer diagnostics firm Pacific Edge has slowed its cash burn on the strength of key wins in its core US market, trimming net losses after tax by a quarter, or $4.7 million, to $14.2m for the year to March.That came off a more than doubling in revenue to $10.4m from a comparable $5.2m in 2020, with operating revenue from test sales at $7.7m, driven by inroads into the commercialisation of its Cxbladder product into international markets.Chief executive David Darling said the result had been achieved despite headwinds created by covid particular...

More Markets

Metroglass recap plan hands control to Amari Metals
Markets

Metroglass recap plan hands control to Amari Metals

An independent report said Metroglass was left with “no viable alternatives”.

Vital presses remaining shareholders to back takeover
Markets

Vital presses remaining shareholders to back takeover

Vital wants shareholders to accept “without delay”.

The problem with wet sock small caps
Markets

Eden Bradfield: The problem with wet sock small caps

Why are smaller firms better off as private companies?

Eden Bradfield 09 Aug 2025
Late selling drives NZ sharemarket down
Markets Market Close

Late selling drives NZ sharemarket down

There were 72 rises and 52 falls on the main board.

Jamie Gray 08 Aug 2025